Cerezyme

Cerezyme is a brand name of imiglucerase, approved by the FDA in the following formulation(s):

CEREZYME (imiglucerase - injectable; injection)

• 
  Manufacturer: GENZYME
  
  Approval date: May 23, 1994
  
  Strength(s): 200 UNITS/VIAL
  


• 
  Manufacturer: GENZYME
  
  Approval date: September 22, 1999
  
  Strength(s): 400 UNITS/VIAL ^[RLD]

Has a generic version of Cerezyme been approved?

No. There is currently no therapeutically equivalent version of Cerezyme available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cerezyme. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Enhanced in vivo uptake of glucocerebrosidase
  Patent 5,549,892
  Issued: August 27, 1996
  Inventor(s): Friedman; BethAnn & Hayes; Michael
  Assignee(s): Genzyme Corporation
  A pharmaceutical composition comprising remodelled recombinant glucocerebrosidase (GCR) is described that provides a therapeutic effect at doses that are lower then those required using remodelled naturally occurring GCR. A method of treating patients with Gaucher's disease using remodelled recombinant GCR is also provided. In vivo uptake of exogenous molecules can be determined by extracting a mixture of cells from a subject, enriching the target cells in vitro, lysing the cells and determining the amount of exogenous molecules.
  
  Patent expiration dates:
  
  
  • August 27, 2013
    
    ✓ 
    Patent use: METHOD OF TREATING A HUMAN SUBJECT HAVING GAUCHER'S DISEASE
  
  

See also...

• Cerezyme Consumer Information (Drugs.com)
• Cerezyme Consumer Information (Wolters Kluwer)
• Cerezyme Consumer Information (Cerner Multum)
• Cerezyme Advanced Consumer Information (Micromedex)
• Cerezyme AHFS DI Monographs (ASHP)
• Imiglucerase Consumer Information (Wolters Kluwer)
• Imiglucerase Consumer Information (Cerner Multum)
• Imiglucerase Intravenous Advanced Consumer Information (Micromedex)
• Imiglucerase AHFS DI Monographs (ASHP)